Fengxiao Zhang
- Molecular Biology
- Cancer Research top 10%
- Epidemiology top 10%
- Oncology top 10%
- Immunology
- Co-authors
- Kai HuangDan HuangMeng DuKun HuangCheng WangXiangrao LiWenjing XuXi Luo
- Topics
- PARP inhibition in cancer therapy (8 papers)Cardiac Fibrosis and Remodeling (5 papers)Lipoproteins and Cardiovascular Health (3 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Fengxiao Zhang
46 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 521
- Cancer Research 272
- Epidemiology 252
- Oncology 250
- Immunology 207
Countries citing papers authored by Fengxiao Zhang
This map shows the geographic impact of Fengxiao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxiao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxiao Zhang more than expected).
Fields of papers citing papers by Fengxiao Zhang
This network shows the impact of papers produced by Fengxiao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxiao Zhang. The network helps show where Fengxiao Zhang may publish in the future.
Co-authorship network of co-authors of Fengxiao Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Fengxiao Zhang. A scholar is included among the top collaborators of Fengxiao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxiao Zhang. Fengxiao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 13 | |
| 7 | 11 | |
| 8 | 3 | |
| 9 | 29 | |
| 10 | 2 | |
| 11 | 11 | |
| 12 | 33 | |
| 13 | 213 | |
| 14 | 92 | |
| 15 | 79 | |
| 16 | 9 | |
| 17 | 26 | |
| 18 | 10 | |
| 19 | 57 | |
| 20 | 26 |
About Fengxiao Zhang
Fengxiao Zhang is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Cancer Research, having authored 48 papers that have together received 1.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), Cardiac Fibrosis and Remodeling (5 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Cancer Research (272 citations), Immunology (207 citations) and Geriatrics and Gerontology (37 citations). Fengxiao Zhang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Kai Huang, Dan Huang, Meng Du, Kun Huang, Cheng Wang, Xiangrao Li, Wenjing Xu, Xi Luo, Minglu Liang and Xin Tan. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.